Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
41,438,714
-
Share change
-
-1,304,741
-
Total reported value
-
$389,495,859
-
Put/Call ratio
-
150%
-
Price per share
-
$9.40
-
Number of holders
-
107
-
Value change
-
-$11,699,385
-
Number of buys
-
29
-
Number of sells
-
64
Institutional Holders of AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) as of Q3 2020
As of 30 Sep 2020,
AMAG PHARMACEUTICALS INC - COMMON STOCK (AMAG) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,438,714 shares.
The largest 10 holders included
BlackRock Inc., Camber Capital Management LP, Camber Capital Management LP, ARMISTICE CAPITAL, LLC, Palo Alto Investors LP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and Bleichroeder LP.
This page lists
107
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.